CNN's Panel on Antisemitism Was a Total Trainwreck
Reporter Gave a Laughable Reason for Why We Can't Trust Polls Now
I'm Not So Sure Bill Clinton Is the Person to Lead Point on...
CBS News' Margaret Brennan Got Wrecked By Scott Bessent and Marty Makary Over...
Watch Scott Jennings Obliterate a Reporter Over Her 'Both Sides' Nonsense on Political...
The Democrats Are the Party of Antisemitic Terrorism
Trump's New Nickname for Joe Biden Is Spectacular
If Democrats Had the Truth on Their Side They Wouldn’t Have to Lie...
They Tried to Silence a Chinese Dissident in America — It Backfired Badly
Hey You, Get Off My Crowd
Hey You, Get Off of My Crowd
Republicans Could Make History on Gun Rights
Trump Cracks Down on Arizona’s Illegal Immigrant Tuition Scheme
Fetterman Breaks with Democrats on Israel, Border, Trump Policies Amid Party Backlash
So, This Is Why ICE Agents Wear Masks
Tipsheet

We're Already Seeing the Effects of Trump Nominating RFK Jr. to HHS

AP Photo/Ross D. Franklin

Vaccine stocks are continuing to fall after President-elect Donald Trump announced he would nominate Robert F. Kennedy Jr. to lead the Department of Health and Human Services. 

Advertisement

“We have a generational opportunity to bring together the greatest minds in science, medicine, industry, and government to put an end to the chronic disease epidemic,” Kennedy said in a statement Thursday after Trump nominated him.  

At 1204 GMT, shares in Britain's GSK (GSK.L), opens new tab were down 3.2% at their lowest in more than a year, while AstraZeneca and France's Sanofi (SASY.PA), opens new tab were down between 2.6% and 2.8% respectively. [...]

Sartorius (SATG.DE), opens new tab, a major supplier of biotech lab gear and substances, fell 3.8%.

Bavarian Nordic (BAVA.CO), opens new tab, which makes a vaccine for mpox, was down 16%, also hurt by third-quarter results

The Danish biotech firm's CEO voiced concerns that RFK Jr, as he is known, could fuel vaccine scepticism but also told Reuters that the U.S. response to the COVID-19 pandemic during Trump's first term made him confident about future bio-defence funding by the incoming U.S. administration.

German-listed shares of BioNtech (22UAy.DE), opens new tab, Pfizer's partner on COVID-19 vaccines, were down more than 10%, set for their biggest one-day fall since August.  [...]

In premarket trading, U.S. vaccine makers fell further after Thursday's declines, with Moderna (MRNA.O), opens new tab down 2.21% after hitting its lowest since April 2020 on Thursday and Novavax (NVAX.O), opens new tab 1.94% lower. 

Pfizer (PFE.N), opens new tab was marginally lower after falling to April lows a day earlier. (Reuters

Advertisement

"For too long, Americans have been crushed by the industrial food complex and drug companies who have engaged in deception, misinformation, and disinformation when it comes to Public Health," Trump said in a statement announcing Kennedy as his pick to lead HHS. "The Safety and Health of all Americans is the most important role of any Administration, and HHS will play a big role in helping ensure that everybody will be protected from harmful chemicals, pollutants, pesticides, pharmaceutical products, and food additives that have contributed to the overwhelming Health Crisis in this Country. Mr. Kennedy will restore these Agencies to the traditions of Gold Standard Scientific Research, and beacons of Transparency, to end the Chronic Disease epidemic, and to Make America Great and Healthy Again!"

Advertisement

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement